18新利赢钱|新利18 苹果

Skip to content Skip to search Skip to footer Ophthalmology & Visual Sciences Open Menu Back Close Menu Search for: Search Close Search Home About UsAbout Us Latest News and Announcements Faculty Directory History Becker Collection EducationEducation Residency ProgramResidency Program Meet the Residents What Distinguishes Us? Application Process Research OpportunitiesResearch Opportunities Ongoing and Completed Research Resident Call Schedule Subspecialty Rotations Living In St. Louis Frequently Asked Questions Clinical FellowshipsClinical Fellowships Meet the Fellows Corneal, External Disease, and Refractive Fellowship Glaucoma Fellowship Ocular Immunology/Uveitis Fellowship Ophthalmic Plastic &＃038; Reconstructive Surgery Fellowship Neuro-Ophthalmology Fellowship Pediatric Ophthalmology and Strabismus Fellowship Vitreoretinal Disease and Surgery Fellowship Optometry Residency Program ResearchResearch DOVS Labs ITVS Pathway T32 Vision Science Training Grant Vision Core GrantVision Core Grant Molecular Genetics Service Core Morphology &＃038; Imaging Core Vision Function Testing Core Graduate Course BIO5501 Student Research Opportunities LASIK Surgery Center Patient CarePatient Care Clinical Specialties Clinical Offices Clinical Trials Prepare for your visit Giving Contact UsContact Us Department Contacts AlumniAlumni Alumni Roster Alumni Videos PhotosPhotos Alumni Photos June 2012 Graduation Welcome Reception 2015 Hardesty Chair 5-31-12 Alumni Newsletters Association Dues EventsEvents Named Lectureship Series DOVS Grand Rounds Archives Open Search Clinical DOVS News Education Residents in the news Research Congrats, Matt Elitt, MD, PhD! By Katarina • April 29, 2024April 29, 2024 Congratulations to WashU Ophthalmology Resident, Matt Elitt, MD, PhD and Case Western Reserve&＃8217;s Tesar Lab colleagues, on the advancement of ION356 to a phase I human clinical trial. Matt Elitt, MD, PhD and Paul Tesar, PhD Dr. Elitt&＃8217;s doctoral research published in Nature demonstrated a novel method to pharmacologically target the pathology of Pelizaeus-Merzbacher disease (PMD), representing the first potential treatment option for patients and their families.  PMD is a lethal pediatric disorder that presents with severe neurological deficits, including nystagmus, optic atrophy, motor impairment, and cognitive disability. You can read more about this trial from the PMD Foundation&＃8217;s announcement. Dr. Elitt completed his doctoral studies in the Tesar Lab at the Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, located in Cleveland, OH. Clinical TrialsResearchResidents John F. Hardesty, MD, Department of Ophthalmology & Visual SciencesWashington University School of MedicineContact Us Facebook Instagram Twitter YouTube AFFILIATE INSTITUTIONS LINKS Faculty Job Openings Staff Job Openings Employee Portal (login required) Join our e-Newsletter mailing list ©2024 Washington University in St. Louis